Documentation of the use of Varitect® CP in patients with herpes zoster, the VARIZOSTA study (NIS-022)

First published 16/02/2023

Last updated 06/03/2024

EU PAS number:

EUPAS103611

Study

Ongoing

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Documentation of the use of Varitect® CP in patients with herpes zoster, the VARIZOSTA study (NIS-022)

Secondary tabs

Share this page